TRACKING SYSTEM FOR ALTERNATIVE METHODS TOWARDS REGULATORY ACCEPTANCE

TSAR indicates the stages methods have reached in terms of acceptance as a recognised test method for use in various sectors together with a summary description. Where available, TSAR also includes relevant records and documents associated with a method linked to the different steps of the entire process: submission, validation, peer-review, recommendations and regulatory acceptance including international standards represented in the tracking system.

Results 41 - 50 of 140
Download (Excel compatible)
LabCyteCORNEAMODEL24 eye irritation test
TM Status: Closed
Test Method Number: TM2015-04 (JAP)
Short Name of TM: LabCyteCORNEAMODEL24 EIT
Responsible Organisation: JaCVAM - Japan
Topic(s): Serious eye damage/Eye irritation
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
LabCyte EPI-MODEL24 skin corrosion test
TM Status: Closed
Test Method Number: TM2017-03 (JAP)
Short Name of TM: LabCyte EPI-MODEL24 SCT
Responsible Organisation: JaCVAM - Japan
Topic(s): Skin Corrosion
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
LabCyte EPI-MODEL24 skin irritation test
TM Status: Closed
Test Method Number: TM2008-14 (JAP)
Short Name of TM: LabCyte EPI-MODEL24 SIT
Responsible Organisation: JaCVAM - Japan
Topic(s): Skin irritation
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
In Chemico Skin Sensitisation: Amino acid Derivative Reactivity Assay
TM Status: Closed
Test Method Number: TM2016-12 (JAP)
Short Name of TM: ADRA for skin sensitization
Responsible Organisation: JaCVAM - Japan
Topic(s): Skin sensitisation
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
Stably Transfected Human Estrogen Receptor-α Transactivation Assay using the (h) ERα-HeLa-9903 cell line
TM Status: Closed
Test Method Number: TM2008-17 (JAP)
Short Name of TM: ER-STTA assay
Responsible Organisation: JaCVAM - Japan
Topic(s): Endocrine disruption
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
Vitrigel-Eye Irritancy Test
TM Status: Closed
Test Method Number: TM2011-15 (JAP)
Short Name of TM: Vitrigel-Eye Irritancy Test
Responsible Organisation: JaCVAM - Japan
Topic(s): Serious eye damage/Eye irritation
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
IL-8 Luciferase assay for skin sensitization
TM Status: Closed
Test Method Number: TM2016-10 (JAP)
Short Name of TM: IL-8 Luciferase assay for skin sensitization
Responsible Organisation: JaCVAM - Japan
Topic(s): Skin sensitisation
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
The Electrophilic Allergen Screening Assay for the Detection of Substances Causing Allergic Contact Dermatitis
TM Status: Open
Test Method Number: TM2016-07 (US)
Short Name of TM: EASA
Responsible Organisation: ICCVAM/NICEATM - United States 
Topic(s): Skin sensitisation
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
Neutral red uptake for starting doses for acute oral toxicity
TM Status: Closed
Test Method Number: TM2003-01 (US)
Short Name of TM: NRU cytotoxicity
Responsible Organisation: ICCVAM/NICEATM - United States 
Topic(s): Acute toxicity,
Basal Cytotoxicity
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
The ToxCast Estrogen Receptor Agonist Pathway Model
TM Status: Closed
Test Method Number: TM2016-08 (US)
Short Name of TM: ToxCast ER Pathway Model
Responsible Organisation: ICCVAM/NICEATM - United States 
Topic(s): Reproductive toxicity,
Endocrine disruption
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards